ConductScience.org, home

Trial · NCT01426763

Results by group118

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 18 h post Dose 10.0455Standard Deviation 0.0624g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 28 h post Dose 10.031Standard Deviation 0.0154g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 124 h post Dose 10.0625Standard Deviation 0.0728g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 224 h post Dose 10.0612Standard Deviation 0.0212g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 148 h post Dose 10.0665Standard Deviation 0.0749g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 248 h post Dose 10.0603Standard Deviation 0.0213g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 1Pre-Dose 20.0243Standard Deviation 0.0234g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 2Pre-Dose 20.0507Standard Deviation 0.0168g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 11 h post Dose 20.0387Standard Deviation 0.0749g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 21 h post Dose 20.00833Standard Deviation 0.00852g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 1120 h post Dose 10.020Standard Deviation 0.00883g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 2120 h post Dose 10.0388Standard Deviation 0.0132g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 1Pre-Dose 30.0288Standard Deviation 0.0644g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 2Pre-Dose 30.00833Standard Deviation 0.0095g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 11 h post Dose 30.00217Standard Deviation 0.00271g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 21 h post Dose 30.004Standard Deviation 0.00405g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 1Pre-Dose 40.006Standard Deviation 0.0119g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 2Pre-Dose 40.0128Standard Deviation 0.00854g/L
Mean Change C1 Inhibitor (C1INH)Subcutaneous (SC) With Recombinant Human Hyaluronidase ph20 (rHuPH20) CYNRYZE Dose 11 h post Dose 40.0193Standard Deviation 0.012g/L
Mean Change C1 Inhibitor (C1INH)SC CINRYZE With rHuPH20 Dose Level 21 h post Dose 40.033Standard Deviation 0.0196g/L

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01426763/results?page=2